Drs. Amyn Habib and Kimmo Hatanpaa, UT Southwestern Medical Center (IMAGE)
Caption
Drs. Amyn Habib (left) and Kimmo Hatanpaa are among the researchers to identify a biological indicator that could eventually provide a new target for therapeutic drugs for brain cancer patients who have the most aggressive forms of the disease.
Credit
UT Southwestern Medical Center
Usage Restrictions
Please use our credit line.
License
Licensed content